What is Targeted Sequencing and Resequencing - Global Market?
Targeted sequencing and resequencing are advanced techniques in genomics that focus on analyzing specific regions of the genome rather than sequencing the entire genome. This approach is particularly useful for identifying genetic variations, mutations, and other genomic features in targeted areas of interest. The global market for targeted sequencing and resequencing has been growing steadily due to its applications in various fields such as clinical diagnostics, personalized medicine, and research. These techniques allow researchers and clinicians to focus on specific genes or regions associated with diseases, enabling more precise and efficient analysis. By concentrating on particular genomic areas, targeted sequencing reduces the time and cost associated with whole-genome sequencing, making it a more accessible option for many laboratories and institutions. The market is driven by advancements in sequencing technologies, increasing demand for personalized medicine, and the growing prevalence of genetic disorders. As the technology continues to evolve, it is expected to play a crucial role in advancing our understanding of genetics and improving healthcare outcomes worldwide.
DNA-based Targeted Sequencing, RNA-based Targeted Sequencing in the Targeted Sequencing and Resequencing - Global Market:
DNA-based targeted sequencing is a method that focuses on sequencing specific regions of the DNA to identify genetic variations, mutations, and other genomic features. This technique is widely used in clinical diagnostics, research, and personalized medicine. By targeting specific genes or regions of interest, DNA-based targeted sequencing allows for a more detailed and accurate analysis of genetic information. It is particularly useful for identifying mutations associated with diseases such as cancer, cardiovascular disorders, and genetic syndromes. The global market for DNA-based targeted sequencing is driven by the increasing demand for personalized medicine, advancements in sequencing technologies, and the growing prevalence of genetic disorders. RNA-based targeted sequencing, on the other hand, focuses on analyzing specific regions of the RNA transcriptome. This technique is used to study gene expression, alternative splicing, and other RNA-related processes. RNA-based targeted sequencing is particularly useful for understanding the functional aspects of the genome and identifying biomarkers for diseases. The global market for RNA-based targeted sequencing is driven by the increasing demand for transcriptome analysis, advancements in sequencing technologies, and the growing interest in RNA-based therapeutics. Both DNA-based and RNA-based targeted sequencing play a crucial role in advancing our understanding of genetics and improving healthcare outcomes. As the technology continues to evolve, it is expected to have a significant impact on various fields, including clinical diagnostics, drug development, and research.
Clinical Application, Plant and Animal Sciences, Drug Development, Others in the Targeted Sequencing and Resequencing - Global Market:
Targeted sequencing and resequencing have a wide range of applications in various fields, including clinical applications, plant and animal sciences, drug development, and others. In clinical applications, targeted sequencing is used to identify genetic mutations associated with diseases, enabling more accurate diagnosis and personalized treatment plans. It is particularly useful in oncology, where it helps in identifying mutations in cancer-related genes, guiding treatment decisions, and monitoring disease progression. In plant and animal sciences, targeted sequencing is used to study genetic variations and traits in different species. It helps in understanding the genetic basis of traits such as disease resistance, yield, and quality, enabling the development of improved crop varieties and livestock breeds. In drug development, targeted sequencing is used to identify genetic targets for drug discovery and development. It helps in understanding the genetic basis of diseases, identifying potential drug targets, and evaluating the efficacy and safety of new drugs. Other applications of targeted sequencing include forensic analysis, where it is used to identify individuals based on their genetic profiles, and population genetics, where it is used to study genetic diversity and evolutionary relationships. The global market for targeted sequencing and resequencing is driven by the increasing demand for personalized medicine, advancements in sequencing technologies, and the growing prevalence of genetic disorders. As the technology continues to evolve, it is expected to have a significant impact on various fields, improving our understanding of genetics and enhancing healthcare outcomes.
Targeted Sequencing and Resequencing - Global Market Outlook:
The global market for targeted sequencing and resequencing was valued at approximately $45 million in 2023. It is projected to grow to an estimated $57 million by 2030, reflecting a compound annual growth rate (CAGR) of 3.6% during the forecast period from 2024 to 2030. This growth is driven by several factors, including advancements in sequencing technologies, increasing demand for personalized medicine, and the growing prevalence of genetic disorders. As more researchers and clinicians recognize the benefits of targeted sequencing, such as its cost-effectiveness and efficiency compared to whole-genome sequencing, the market is expected to expand further. The ability to focus on specific genomic regions allows for more precise analysis, making it an attractive option for various applications, including clinical diagnostics, drug development, and research. Additionally, the increasing availability of sequencing platforms and the development of new bioinformatics tools are expected to further drive market growth. As the technology continues to evolve, it is anticipated to play a crucial role in advancing our understanding of genetics and improving healthcare outcomes worldwide.
| Report Metric | Details |
| Report Name | Targeted Sequencing and Resequencing - Market |
| Forecasted market size in 2030 | US$ 57 million |
| CAGR | 3.6% |
| Forecasted years | 2024 - 2030 |
| Segment by Type: |
|
| Segment by Application |
|
| By Region |
|
| By Company | Agilent Technologies, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, DNASTAR, PacBio, Bio-Rad Laboratories, Integrated DNA Technologies, Perkin Elmer, RainDance Technologies, PierianDx, BGI, Genomatix GmbH, Macrogen, GATC Biotech Ag, Oxford Nanopore Technologies, QIAGEN |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
